【摘要】 中医是中华文明的瑰宝，其独特的整体观、辨证观和平衡观拥有丰富多样的治疗手段。传承创新对于中医药事业的发展至关重要，通过分析“肾主骨理论”“脾肾相关论”“血瘀论”研究骨质疏松症(osteoporosis, OP)的病机与防治，现已取得显著的效果。黄宏兴教授课题组深耕该领域多年，将OP的中医证型归为脾肾阳虚、肝肾阴虚和肾虚血瘀三型，并以补肾、健脾、活血为治则，优化了其中医临床路径，重视患者的生存质量，从脾肾、肌骨和线粒体与OP的发生为研究的切入点，推崇肌骨同治理念，总结提炼出“脾肾-肌骨-线粒体理论”体系，进一步将宏观和微观联系起来开展OP的发病机制和中药复方干预作用研究，进一步丰富了中医药防治OP的理论体系。更多还原

【Abstract】 TCM is a treasure of Chinese civilization. It has a unique holistic view, a dialectical view and a balance view, and has a variety of treatment method. Inheritance and innovation are crucial to the development of TCM. By analyzing the theory of “Kidney Governing Bone”, “Spleen-Kidney Correlation Theory”, and “Blood Stasis Theory”, the pathogenesis and prevention of osteoporosis have been studied, and remarkable result have been achieved. Professor Huang Hongxing’s research group has been deeply engaged in this field for many years, and classified the TCM syndromes of osteoporosis into three types: spleen-kidney yang deficiency, liver-kidney yin deficiency and kidney deficiency and blood stasis. The clinical path of traditional Chinese medicine attaches great importance to the quality of life of patients, starts with the occurrence of spleen-kidney, musculoskeletal and mitochondria and osteoporosis, forms the concept of musculoskeletal treatment, and summarizes the “spleen-kidney-musclebone-mitochondria theoretical system”, and further connect the macro and micro to carry out research on the pathogenesis of osteoporosis and the intervention effect of TCM compound, which further enriches the theoretical system of TCM for the prevention and treatment of osteoporosis.更多还原